Roche Holding AG Basel American Depositary Shares (RHHBY)
$38.49
0.00 (0.00%)
RHHBY Stock Quote Delayed 15 Minutes
Previous Close
$38.49
Market Cap
262.92B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
Day's Range
38.49 - 38.49
52-Week Range
25.10 - 38.87
Dividend & Yield
0.92 (2.39%)
RHHBY Stock Predictions, Articles, and Roche Holding AG Basel American Depositary Shares News
Why NewLink Genetics Corp (NLNK), Urban Outfitters, Inc. (URBN) and Dell Technologies Inc (DVMT) Are 3 of Today’s Worst Stocks
Dell Technologies (DVMT), NewLink Genetics (NLNK) and Urban Outfitters (URBN) shareholders couldn't wait for Thursday's action to come to a close.
3 Cheap Biotech Stocks The Big Boys Are Buying (BLRX, OMED, FWP)
Biotechnology is among the most exciting and lucrative sectors for investors, and these 3 biotech stocks stand out...
iShares MSCI EAFE Index Fund (ETF) (EFA): The Quick Guide to EFA
The iShares MSCI EAFE ETF (EFA) holds nearly 940 stocks based outside the U.S. Is the EFA the right way to get international exposure?
Here’s How You Can Invest In The World’s Most Innovative Country: Switzerland (EWL)
I've uncovered a data set that show Switzerland as the most innovative country in the world. Here's how to take advantage...
Roche Holding Ltd. (ADR) (RHHBY) Stock Is Weathering the Healthcare Storm
Roche has plenty of great drugs under its umbrella and RHHBY stock should do well no matter what the government decides to do.
Roche Holding Ltd. (RHHBY) Still Has a Few Tricks Up its Sleeve
The Big Pharma is set to have a very good 2017 and put 2016 behind it.
5 Healthcare Stocks Poised to Trump Q3 Earnings
Medical is one of the sectors that is witnessing earnings and revenue growth this quarter, and these 5 healthcare stocks are set to beat
Eleven Biotherapeutics Inc (EBIO) Soars on Roche Holding Ltd. (ADR) Deal
Eleven Biotherapeutics stock soared on Monday following news of its deal with Roche concerning its Interleukin-6 technology.
Johnson & Johnson: My Favorite Dividend King (JNJ)
Johnson & Johnson is one of the strongest dividend payers the market's have to offer. Here's why I'm willing to pay a premium to own JNJ stock
How Big Data & Big Pharma Will Transform Drug Development
Big data can be used by big pharma companies like Roche to drastically cut costs, increase drug production and drive long-term stock gains.
U.S. Debut of Biosimilar Drugs Threatens Major Biotechs
The introduction of biosimilar drugs will change the biotech landscape ... especially for these three names.
Will Lower Oil Mean Higher Q4 Earnings?
With Q4 earnings season upon us, better-than-expected gains from companies based partly or mostly on lower oil prices may be just the salve the market needs to regain some traction.
Add Roche to Your List of Ebola Stocks, But …
Ebola stocks have doled out some big gains to savvy traders this year, but investors looking for Roche (RHHBY) to do the same may want to rethink their expectations.
Gilead Stock Will Rise on Sovaldi® Sales
Gilead's breakthrough Hepatitis C drug, Sovaldi®, will drive revenue and profits for the rest of 2014 and into 2015.
Roche Proves You Can’t Judge a Book by Its Cover
Roche stock may not be an NYSE or NASDAQ-listed equity, but when you look at the details, RHHBY is plenty investment-worthy.
3 Huge Healthcare Trends Can Fatten Your Portfolio
Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities
